Kelly Crowe

Medical science

Kelly Crowe is a medical sciences correspondent for CBC News, specializing in health and biomedical research. She joined CBC in 1991, and has spent 25 years reporting on a wide range of national news and current affairs, with a particular interest in science and medicine.

Latest from Kelly Crowe

Second Opinion

Solving the mystery of the weight-loss plateau

Why the body’s calorie-burning capacity drops has so far not been explained. There are theories that something puts the brakes on the body’s ability to turn up its fat-burning machinery and a new paper describes one possible system.
Second Opinion

Are food politics defeating Canada's healthy eating strategy?

With the clock ticking toward a federal election, time is running out for the Trudeau government's signature healthy eating strategy. The law banning the advertisement of junk food to kids died in the Senate last month. Advocates are now worried that new front-of-package food labelling rules won't happen.
Second Opinion

Listeria risk from recalled packaged kale highlights pathogen's challenge

This is the third time in eight months that an Eat Smart product has been recalled in Canada because of Listeria, one of the most dangerous foodborne pathogens.
Second Opinion

A stem cell 'cautionary tale' as Health Canada cracks down on private clinics

Canada's stem cell controversy heated up this week as Health Canada ordered private clinics to stop so-called "stem cell" treatments. At the same time, a St. John's radiologist published a gruesome story about a stem cell treatment that went terribly wrong.
Second Opinion

Mice are not people: Fighting spin in medical science

When it comes to health and science research, spin exaggerates the benefit of a treatment and plays down the risks. And spin can affect how people judge the benefit of treatments they read about in the news, according to the first randomized controlled trial to test the effect of spin on readers.
Second Opinion

Why did deer meat from an infected herd end up in Canada's food chain?

Scientists still don't know whether chronic wasting disease is a human health risk. But there is emerging evidence by Canadian researchers that this deadly animal disease could jump the species barrier. That's why some scientists are calling on Ottawa to take greater precautions.
Second Opinion

Breaking down the walls of scientific secrecy

A Canadian research team is pushing the boundaries of transparency in biomedical science by publishing their research notes in real time and refusing to patent their discoveries.
Second Opinion

'You disappointed us': Why is Canada opposing more transparency in drug prices?

Frustration at the pharmaceutical industry's high prices and secrecy bubbled over at the World Health Assembly this week as delegates fought for a strongly-worded resolution calling for greater transparency in the cost of clinical trials, drug R&D and prices. But some countries, including Canada, pushed for softer wording that could maintain secrecy in prices and research.
Second Opinion

'Stem cell' therapies offered at private clinics need to be approved as drugs, Health Canada says

Across Canada, private clinics charge thousands of dollars for injections and IV therapies using what they claim are stem cells. This week, Health Canada ruled that those cell therapies are drugs that must be approved. But so far, the agency has not ordered clinics to stop doing the procedures.
Second Opinion

2 young Canadian brothers, a life-threatening disease — and the harsh reality of drug prices

This week's story of two young Canadian brothers with cystic fibrosis reveals a bleak reality — only one has access to a promising new medication in a clinical trial, while a similar drug that could help his brother is too expensive. But access to the manufacturer's drugs is not just a problem in Canada. There are bitter fights in other jurisdictions over how much the company is charging.
Second Opinion

Cigarettes in plain packages — it only took 25 years

Big tobacco successfully delayed plain packaging laws in Canada for a quarter of a century. But the long awaited public health measure comes into force just as the tobacco industry says its moving beyond cigarettes into a new "smoke-free" future.
Second Opinion

11th-hour lobbying by industry could kill law banning food marketing to kids

It wasn't long ago that all parties supported a federal law to ban food marketing to kids. But a combination of partisan politics and industry lobbying has some fearing the law will die as the clock ticks toward the federal election.
Second Opinion

Nova Scotia's health care 'crisis' is Canada's crisis too

Nova Scotia's health-care system came under fire this week when a tearful patient's angry video went viral, blaming the province's doctor shortage for her delayed cancer diagnosis. But it's not just Nova Scotia. The same problems are happening across Canada.
Second Opinion

What happened to triclosan? A lingering legacy of the hyper-hygiene era

A few years ago we were brushing our teeth with it, rinsing our mouths with it, sanitizing our hands with it. And now triclosan is almost vanished from the marketplace.
Second Opinion

'Help!' Health Canada asks Canadians for advice on problem of youth vaping

Health Canada has asked Canadians for 'advice' on ways to prevent vaping from becoming 'normalized among young people.' Meanwhile, one tobacco giant reports an increase in 'poly-usage,' as new vaping products put it 'back in a growth industry.'